Skip to main content

Table 7 Distribution of reported adverse events by treatment arm

From: Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial

Adverse eventsControl armIntervention arm
Fever, n (%)7 (30.4)3 (13.6)
Abdominal pain, n (%)4 (17.4)4 (18.2)
Headache, n (%)3 (13.0)4 (18.2)
Asthenia, n (%)3 (13.0)3 (13.6)
Dizziness, n (%)3 (13.0)2 (9.1)
Vomiting, n (%)1 (2.3)3 (13.6)
Nausea, n (%)1 (2.3)3 (13.6)
Rashes, n (%)1 (2.3)0 (0)
Diarrhoea, n (%)0 (0)0 (0)
Total N (%)23 (100)22 (100)